Teyro Labs Private Limited is a well-known pharmaceutical manufacturer in India, an expert in sterile injectables, oral solid dosage, and oncology medicines. The company provides contract manufacturing and CDMO services for pharmaceutical companies for international markets.
Manufacturing from a USFDA-registered and EU GMP-approved facility, Teyro Labs uses the latest technology, modern manufacturing systems, and quality standards to ensure safe and reliable pharmaceutical production.
The company manufactures liquid injectables, lyophilized injectables, and oral solid dosage solutions, while providing product development, quality guarantee, and regulatory-compliant production solutions for international pharmaceutical brands.
| Basic Information | |
|---|---|
| Nature of Business | Manufacturer, Contract Manufacturer, CDMO (Contract Development & Manufacturing Organization), Pharmaceutical Manufacturer |
| Additional Business |
|
| Company CEO | Manish Choube |
| Registered Manufacturing Address | No. 13 (Old 29), Thilak Street, Parthasarathi Puram, T. Nagar, Chennai – 600017, Tamil Nadu, India |
| Total Number of Employees | 175-500 Employees |
| Manufacturing Facilities | USFDA-registered and EU GMP-approved oncology manufacturing facility equipped with advanced isolator technology, Closed Restricted Access Barrier System (cRABS), automated BOSCH filling line, lyophilization, sterilization systems, and oral solid dosage manufacturing infrastructure for sterile and non-sterile pharmaceutical products. |
| Established Year | 2016 |
| Legal Status of Firm | Private Limited Company |
| Quality Measures or Testing Facilities | USFDA-registered and EU GMP-approved manufacturing facility with advanced Quality Control and Quality Assurance systems, aseptic manufacturing processes, sterility assurance, in-process quality monitoring, and compliance with international pharmaceutical regulatory standards. |
| Statutory Profile | |
| GST No. | 33AAMCA4396C1ZQ |
| Payment Details | |
| Payment Mode |
|
| Shipment Mode |
|
Leave a Reply